Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Interim Management Statement

25 Apr 2014 07:00

RNS Number : 4762F
Gleeson(M J)Group PLC
25 April 2014
 



Gleeson (MJ) Group PLC

(GLE.L)

 

Interim Management Statement

 

Gleeson (GLE.L), the urban regeneration and strategic land specialist, announces its Interim Management Statement, covering the period from 1 January 2014 to 31 March 2014.

 

Gleeson has two divisions:

 

· Gleeson Homes An urban regeneration specialist in the North of England, with a particular focus on low cost family homes

 

· Gleeson Strategic Land A strategic land promotion business, mainly in the South of England, that enhances the value of land through the planning process and sells it to developers

 

Gleeson Homes

 

Gleeson Homes has continued to perform well with reservations taken in the period significantly higher than the prior period. The business currently has 37 active sites, compared with 29 in the corresponding period last year.

 

The Board expects to record more than 540 completions in the year to 30 June 2014, a 33% increase on the 406 units completed in the prior year.

 

Total sales year to date, comprising reserved, contracted and completed homes, are up 63% on last year, meaning that the Group will enter the next financial year with a strong forward order book. 

 

Gleeson Homes is in active discussions regarding the acquisition of a further 10 sites which, if purchased, will add 1,300 plots to the regeneration land pipeline, taking the total number of plots to in excess of 6,100.

 

The Government's "Help to Buy" initiative continues to be a popular scheme for our customers, with 31% of the completions in the year taking advantage of the scheme.

 

Gleeson Strategic Land

 

Gleeson Strategic Land continued to perform in line with expectations during the period, enhancing its portfolio and progressing sites through the planning system. In line with increasing activity in the housing market, there has been a further improvement in the prices that volume housebuilders are willing to pay for green field residential land in the South of England.

 

The business currently has eight sites with planning permission. Six of these sites, comprising 706 plots, are being progressed for sale in the current financial year. If all of these sales are achieved, the division will contribute a higher level of profit than in any financial year since 2007.

 

The strategic portfolio consists of 67 sites totalling 3,811 gross acres, which have the potential to deliver 21,900 plots. There are currently 15 sites either with submitted planning applications or with a planning appeal lodged, which have the potential to deliver 100 acres of commercial land, a 60 bed nursing home and in excess of 2,000 plots.

 

Outlook

 

The Board is encouraged by the achievements of both Gleeson Homes and Gleeson Strategic Land and remains confident that there will be further substantial improvements in the Group's trading performance in both the current year and beyond. Although planning delays have created some uncertainty with respect to the exact number of land sales that will be achieved within the current financial year, the Group's profit for the full year is expected to be in line with, or possibly better than, current market expectations.

 

 

 

25 April 2014

Enquiries:

MJ Gleeson Group plc

Tel: +44 1252 360 300

Jolyon Harrison

Chief Executive Officer

Alan Martin

Chief Financial Officer

Instinctif

Tel: +44 20 7457 2020

Mark Garraway

Helen Tarbet

N+1 Singer

Shaun Dobson

Tel: +44 20 7496 3000

Gillian Martin

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFMGZDKDGGDZM
Date   Source Headline
12th Feb 20254:14 pmRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSResults for the half year ended 31 December 2024
7th Feb 202511:51 amRNSDirector/PDMR Shareholding
14th Jan 20257:00 amRNSTrading Update & Notice of Results
7th Jan 20254:28 pmRNSDirector/PDMR Shareholding
9th Dec 20244:59 pmRNSDirector/PDMR Shareholding
3rd Dec 20243:50 pmRNSDirector/PDMR Shareholding
26th Nov 20243:34 pmRNSDirector/PDMR Shareholding
15th Nov 20242:08 pmRNSResult of AGM
15th Nov 20247:00 amRNSAGM Trading Update
7th Nov 20242:44 pmRNSDirector/PDMR Shareholding
30th Oct 202410:42 amRNSDirector/PDMR Shareholding
21st Oct 20247:00 amRNSNotice of AGM
18th Oct 20244:24 pmRNSDirector/PDMR Shareholding
18th Oct 20244:19 pmRNSDirector/PDMR Shareholding
9th Oct 20244:27 pmRNSDirector/PDMR Shareholding
4th Oct 202410:18 amRNSDirector/PDMR Shareholding
30th Sep 20247:00 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSAudited results for the year ended 30 June 2024
9th Sep 202410:18 amRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSTotal Voting Rights
7th Aug 20249:41 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSTotal Voting Rights
23rd Jul 20242:36 pmRNSDirector/PDMR Shareholding
23rd Jul 20241:53 pmRNSStandard form for notification of major holdings
11th Jul 20247:00 amRNSFY2024 Trading Update
8th Jul 20241:34 pmRNSDirector/PDMR Shareholding
8th Jul 20247:00 amRNSNotice of Trading Update
28th Jun 20247:00 amRNSTotal Voting Rights
6th Jun 20242:46 pmRNSDirector/PDMR Shareholding
31st May 20247:00 amRNSTotal Voting Rights
15th May 20247:00 amRNSAppointment of Joint Corporate Broker
9th May 20249:41 amRNSDirector/PDMR Shareholding
30th Apr 20247:00 amRNSTotal Voting Rights
8th Apr 20243:41 pmRNSDirector/PDMR Shareholding
3rd Apr 20244:28 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:28 pmRNSDirector/PDMR Shareholding
28th Mar 20247:00 amRNSTotal Voting Rights
22nd Mar 20249:07 amRNSDirector/PDMR Shareholding
20th Mar 20241:45 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSTotal Voting Rights
26th Feb 20241:04 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSResults for the half year ended 31 December 2023
7th Feb 202411:34 amRNSDirector/PDMR Shareholding
31st Jan 20247:00 amRNSTotal Voting Rights
9th Jan 202410:50 amRNSDirector/PDMR Shareholding
9th Jan 20247:00 amRNSTrading Update & Notice of Results
29th Dec 20237:00 amRNSTotal Voting Rights
15th Dec 20232:49 pmRNSRe Directorate External Appointments
6th Dec 20234:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.